240 related articles for article (PubMed ID: 17245225)
21. Efficacy of famciclovir treatment in chronic hepatitis B patients with different mutations at position 552 of the DNA polymerase gene.
Wolters LM; Honkoop P; Niesters HG; de Man RA
J Hepatol; 1998 May; 28(5):909-10. PubMed ID: 9625328
[No Abstract] [Full Text] [Related]
22. Comparison of the efficacy of lamivudine and famciclovir in Asian patients with chronic hepatitis B: results of 24 weeks of therapy.
Lai CL; Yuen MF; Hui CK; Garrido-Lestache S; Cheng CT; Lai YP
J Med Virol; 2002 Jul; 67(3):334-8. PubMed ID: 12116023
[TBL] [Abstract][Full Text] [Related]
23. Is nucleoside analogue monotherapy sufficient for treatment of HBV infection? Lessons from HIV.
Pillay D; Cane PA; Mutimer D
Sex Transm Infect; 1999 Apr; 75(2):87-8. PubMed ID: 10448359
[No Abstract] [Full Text] [Related]
24. A single-center, prospective and randomized controlled study: Can the prophylactic use of lamivudine prevent hepatitis B virus reactivation in hepatitis B s-antigen seropositive breast cancer patients during chemotherapy?
Long M; Jia W; Li S; Jin L; Wu J; Rao N; Feng H; Chen K; Deng H; Liu F; Su F; Song E
Breast Cancer Res Treat; 2011 Jun; 127(3):705-12. PubMed ID: 21445574
[TBL] [Abstract][Full Text] [Related]
25. Hepatitis B virus resistance to antivirals: clinical implications and management.
Zoulim F
J Hepatol; 2003; 39 Suppl 1():S133-8. PubMed ID: 14708691
[No Abstract] [Full Text] [Related]
26. Additional interferon alpha for lamivudine resistant hepatitis B infection after liver transplantation: a preliminary report.
Seehofer D; Rayes N; Berg T; Neuhaus R; Hopf U; Müller AR; Bechstein WO; Neuhaus P
Transplantation; 2000 Apr; 69(8):1739-42. PubMed ID: 10836394
[TBL] [Abstract][Full Text] [Related]
27. Combined lamivudine and interferon-alpha therapy for chemotherapy-induced reactivation of hepatitis B virus.
Ohmoto K; Tsuduki M; Yamamoto S
Am J Gastroenterol; 2003 May; 98(5):1215-6; author reply 1217. PubMed ID: 12809863
[No Abstract] [Full Text] [Related]
28. Long-term follow-up of HIV/HBV coinfected patients from a Greek center.
Elefsiniotis IS; Mpotsi C; Paparizos V; Pantazis KD
J Clin Virol; 2004 Jul; 30(3):280-1. PubMed ID: 15135750
[No Abstract] [Full Text] [Related]
29. Lamivudine therapy for chemotherapy-induced reactivation of hepatitis B virus infection.
Ahmed A; Keeffe EB
Am J Gastroenterol; 1999 Jan; 94(1):249-51. PubMed ID: 9934765
[TBL] [Abstract][Full Text] [Related]
30. Prophylaxis and treatment of hepatitis B virus reinfection following liver transplantation.
Zheng SS; Wu J; Liang TB; Wang WL; Huang DS; Xu X
Hepatobiliary Pancreat Dis Int; 2002 Aug; 1(3):327-9. PubMed ID: 14607701
[TBL] [Abstract][Full Text] [Related]
31. Chronic hepatitis B: interferon-monotherapy or combination with nucleoside analogues?
Tassopoulos NC
Liver; 1998 Apr; 18(2):71-2. PubMed ID: 9588765
[No Abstract] [Full Text] [Related]
32. Comparison of famciclovir and lamivudine in the long-term treatment of hepatitis B infection after liver transplantation.
Rayes N; Seehofer D; Hopf U; Neuhaus R; Naumann U; Bechstein WO; Neuhaus P
Transplantation; 2001 Jan; 71(1):96-101. PubMed ID: 11211203
[TBL] [Abstract][Full Text] [Related]
33. The difficulties of managing severe hepatitis B virus reactivation.
Roche B; Samuel D
Liver Int; 2011 Jan; 31 Suppl 1():104-10. PubMed ID: 21205146
[TBL] [Abstract][Full Text] [Related]
34. A prospective study on chemotherapy-induced hepatitis B virus reactivation in chronic HBs Ag carriers with hematologic malignancies and pre-emptive therapy with nucleoside analogues.
Yağci M; Acar K; Sucak GT; Aki Z; Bozdayi G; Haznedar R
Leuk Lymphoma; 2006 Aug; 47(8):1608-12. PubMed ID: 16966273
[TBL] [Abstract][Full Text] [Related]
35. Cell-mediated immune responses and loss of hepatitis B e-antigen (HBeAg) during successful lamivudine and famciclovir combination therapy for chronic replicating hepatitis B virus infection.
Hultgren C; Weiland O; Milich DR; Sällberg M
Clin Infect Dis; 1999 Dec; 29(6):1575-7. PubMed ID: 10585820
[No Abstract] [Full Text] [Related]
36. Nucleoside analogues and other investigational modalities for the treatment of chronic hepatitis B.
Fried MW; Sommadossi JP
Antivir Ther; 1996 Apr; 1(2):71-6. PubMed ID: 11321182
[No Abstract] [Full Text] [Related]
37. Long-term outcome of tenofovir disoproxil fumarate use against hepatitis B in an HIV-coinfected cohort.
Alvarez-Uria G; Ratcliffe L; Vilar J
HIV Med; 2009 May; 10(5):269-73. PubMed ID: 19210695
[TBL] [Abstract][Full Text] [Related]
38. Sequential combination therapy of HBe antigen-negative/virus-DNA-positive chronic hepatitis B with famciclovir or lamivudine and interferon-alpha-2a.
Schiefke I; Klecker C; Maier M; Oesen U; Etzrodt G; Tannapfel A; Liebert UG; Berr F
Liver Int; 2004 Apr; 24(2):98-104. PubMed ID: 15078472
[TBL] [Abstract][Full Text] [Related]
39. Treatment of recurrent hepatitis B infection in liver transplant recipients.
Terrault NA
Liver Transpl; 2002 Oct; 8(10 Suppl 1):S74-81. PubMed ID: 12362303
[TBL] [Abstract][Full Text] [Related]
40. The effect of lamivudine on the replication of hepatitis B virus in HIV-infected patients depends on the host immune status (CD4 cell count).
Haverkamp M; Smit M; Weersink A; Boucher CA; Hoepelman AI
AIDS; 2003 Jul; 17(10):1572-4. PubMed ID: 12824802
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
